Press release archives - Medical/Pharmaceuticals

Subscribe to India PRwire Breaking News RSS Feed to instantly access 25 most recent press releases across our network. If you are only interested in Medical/Pharmaceuticals industry press releases, subscribe to our Medical/Pharmaceuticals RSS feed.

Thursday, 30th May 2013

Bilcare secures Abbott's export, offers track-n-trace and authentication technology

Bilcare, India's leading innovation-driven technology solution company has been associated with Abbot, country's fastest growing pharmaceutical company, to provide secure, non-clonable 'Track & Trace technology' for protection of Abbott's exports across globe. More...

  • Published on May 30, 13
Taj Pharmaceuticals Announces Issuance of US Patent for Terfenadine

Taj Pharma India, Extends exclusivity to Terfenadine Generic Patent used for antihistamine formerly used for the treatment of allergic conditions More...

  • Published on May 30, 13

Wednesday, 22nd May 2013

Dr. Huzaifa Khorakiwala Receives The Rajiv Gandhi Global Excellence Award

Noted social worker and CEO - Wockhardt Foundation, Dr. Huzaifa Khorakiwala, was awarded with "The Rajiv Gandhi Global Excellence Award" on the May 21, 2013, at New Delhi, marking the Death Anniversary of Former Prime Minister, Shri Rajiv Gandhi. The Award was given by Honorable Governor of Uttarakhand, Shri Aziz Qureshi. More...

  • Published on May 22, 13

Saturday, 18th May 2013

MIOT International announces First Ever Haplo-identical Transplant for treating Blood Cancers in India

MIOT Hospitals has for the first time in India came out successful with the Haploid-Identical transplant for treating blood related disorders (Blood Cancers - Leukemia, Lymphomas and myelomas) More...

  • Published on May 18, 13

Thursday, 16th May 2013

Bilcare secures Biocon export, offers track-n-trace and authentication technology

Bilcare, India's leading innovation-driven technology solution company has been associated with Biocon, country's largest biopharma company, to provide secure, non-clonable 'Track & Trace technology' for protection of Biocon's exports across globe. More...

  • Published on May 16, 13

Friday, 3rd May 2013

Intas launches "Mabtas", its biosimilar version of Rituximab

Cancer care is costly. It drains families emotionally and financially. With a view to make Non-Hodgkin's Lymphoma (NHL) treatment cost-effective, Intas Pharmaceuticals Limited has launched "Mabtas" in India. More...

  • Published on May 3, 13

Wednesday, 17th Apr 2013

EISAI India Wins CII Excellence Award

Eisai Pharmatechnology & Manufacturing Pvt. Ltd, Visakhapatnam (EISAI) has been awarded the prestigious Environment, Health, and Safety (EHS) Excellence 2012 Award by the Confederation of Indian Industry CII (Southern Region). More...

  • Published on Apr 17, 13

Thursday, 28th Feb 2013

8th Nutra India Summit to kick off from March 13 In Mumbai

This year the 8th Nutra India Summit, India's biggest Nutraceutical, Functional Foods, Dietary Supplements and Ingredients Show will be held in Mumbai from 13th March to 16th March 2013. More...

  • Published on Feb 28, 13

Friday, 15th Feb 2013

FICCI-CASCADE And Partnership For Safe Medicines (Psm) India Call For Accessibility Of Safe Medicines For All Consumers

FICCI CASCADE (Committee Against Smuggling and Counterfeiting Activities Destroying the Economy) and PSM (Partnership for Safe Medicines) India, organized an Open House consultation on "Accessibility to safe and quality medicines in the supply chain in India". For the first time in India as a pilot, patients can get their medicines tested in accredited Government approved ... More...

  • Published on Feb 15, 13

Sunday, 10th Feb 2013

Consulting firm Ma Foi forays into the Rs. 90,000-crore, fast growing pharmaceutical industry

Acquires 17.5% stake in Coimbatore-based Pharmacovigilance services start-up Oviya MedSafe to reiterate its commitment towards consulting in the SME space More...

  • Published on Feb 10, 13

Monday, 28th Jan 2013

GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries

GlaxoSmithKline (GSK) and Biological E Limited (Biological E.), a leading Indian vaccines company, today announced an agreement to form a 50/50 joint venture (JV) for the early stage research and development of a six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases. More...

  • Published on Jan 28, 13

Thursday, 24th Jan 2013

Max Healthcare Awarded Best Corporate Website at the 3rd India Digital Awards

Internet and Mobile Association of India [IAMAI] felicitated Max Healthcare for the Best Corporate Website award at the recently held 3rd India Digital Awards. Chosen from among 200 entries in the category, Max Healthcare was acknowledged with this prestigious award for being the most audience engaging and relevant corporate website. Olive e-Business Pvt. Ltd is the websit... More...

  • Published on Jan 24, 13

Thursday, 3rd Jan 2013

Dr. Reddy's announces the Launch of Finasteride Tablets

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Finasteride Tablets (1 mg), a bioequivalent generic version of Propecia® (Finasteride) Tablets in the US market on January 02, 2013. Dr. Reddy's ANDA for Finasteride 1 mg Tablets has been awarded a 180-day period of marketing exclusivity in the U.S. on 2 Jan, 2013. More...

  • Published on Jan 3, 13

Monday, 19th Nov 2012

Dr. Reddy's announces the Launch of Sildenafil Tablets

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets. More...

  • Published on Nov 19, 12

Tuesday, 30th Oct 2012

Dr. Reddy's Q2 & H1 FY13 Financial Results

Dr. Reddy's Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended September 30, 2012 under International Financial Reporting More...

  • Published on Oct 30, 12